06/12/2025 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/10/2025 7:47 PM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2025 8:47 PM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2025 5:15 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2025 8:33 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/19/2025 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/12/2025 5:03 AM | Radiopharm Theranostics (Subject) REGAL FUNDS MANAGEMENT PTY LTD (Filed by)
| Form SCHEDULE 13G | |
04/29/2025 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2025 7:05 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/17/2025 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2025 7:30 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for RADX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Radiopharm Theranostics and its competitors with MarketBeat's FREE daily newsletter.
|
03/07/2025 5:20 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 3:45 PM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/25/2025 5:22 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/24/2025 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 7:03 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2025 11:16 AM | JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by) Radiopharm Theranostics (Subject)
| Form SCHEDULE 13G | |
02/10/2025 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2025 5:08 AM | Radiopharm Theranostics (Subject) REGAL FUNDS MANAGEMENT PTY LTD (Filed by)
| Form SCHEDULE 13G | |
01/21/2025 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/10/2025 6:30 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 5:31 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024 7:00 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2024 7:28 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/15/2024 11:15 PM | Radiopharm Theranostics (Filer)
| Form EFFECT | |
12/13/2024 8:45 AM | Radiopharm Theranostics (Filer)
| Form 424B3 | |
12/10/2024 5:23 AM | Radiopharm Theranostics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024 3:02 PM | Radiopharm Theranostics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
11/27/2024 9:29 AM | Deutsche Bank Trust Co Americas/ ADR Group (Filed by) Radiopharm Theranostics (Subject)
| Form F-6/A | |
11/27/2024 9:00 AM | Radiopharm Theranostics (Filer)
| Form SEC STAFF ACTION | |
11/25/2024 1:32 PM | Radiopharm Theranostics (Filer)
| Form CERT | |
10/25/2024 5:21 AM | Deutsche Bank Trust Co Americas/ ADR Group (Filed by) Radiopharm Theranostics (Subject)
| Form F-6/A | |
10/21/2024 5:12 AM | Radiopharm Theranostics (Filer)
| Form 20FR12B/A | |
09/25/2024 5:07 AM | Radiopharm Theranostics (Filer)
| Form 20FR12B/A | |
09/11/2024 3:53 PM | Deutsche Bank Trust Co Americas/ ADR Group (Filed by) Radiopharm Theranostics (Subject)
| Form F-6 Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
09/09/2024 5:10 AM | Radiopharm Theranostics (Filer)
| Form 20FR12B/A | |
07/25/2024 7:43 AM | Radiopharm Theranostics (Filer)
| Form 20FR12B/A | |